Privacy Policy
Signals Blog

Contributors

Categories

Cell Therapy Deal Review: March

Welcome to your Cell Therapy Deal Review for the month of March. Cellectis continues to differentiate through a collaboration with MabQuest. PCT formed a partnership with Japanese conglomerate Hitachi. Kite partnered with Roche’s Genentech on a program for lymphoma....

Right Turn: Autism stem cell research could use a boost

While I’m sure news about autism spikes in April during the annual awareness campaign, I doubt autism is absent from the news very often. Whether parents and advocates are lobbying for more services and funding, experts and non-experts are arguing over whether...

Athletes embrace stem cell therapy, for better or worse

Randi Druzin is an author and journalist based in Toronto. She has worked at the CBC and several other major media outlets, and has written for publications such as The New York Times and The Globe and Mail. She has also written three books. Randi first learned about...

Right Turn: A science book lover’s dream list

I’ve written about the Canadian Science Writers’ Association (CSWA) before, in a post about good stem cell books for kids. Well, CSWA has just released its Short Lists in the 2015 Science in Society Book Awards competition, and with CBC’s Canada Reads having just...

A double duty scaffold for cell delivery to the brain

Neurodegenerative diseases of the brain, such as Parkinson’s and Alzheimer’s, are a leading cause of disability in Canada, but despite the significant burden on patients, caregivers and the health-care system, we still lack a cure. An active area of research for these...

Right Turn: The wait is over

For nearly 2 million people, the restless nights, anxious days, over-caffeinated spiral is almost over. On April 14th, Orphan Black returns with its fourth season. A few Christmases ago, I compiled a list of television shows and movies that feature stem cells in a...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!